| Aug 19 2025 |
What You Need to Know: Texas Substantially Expands Medical Cannabis Program |
Bradley Arant Boult Cummings LLP |
| Aug 19 2025 |
Bipartisan Bill Would Strengthen American Biomanufacturing |
Bergeson & Campbell, P.C. |
| Aug 18 2025 |
MN Rewrote the MinnesotaCare Tax Rules — But Tax Committees Never Saw It Coming |
Jones Walker LLP |
| Aug 18 2025 |
The FTC Goes All In on Head-To-Head Competition for Pipeline Medical Devices Merger Challenge |
Katten |
| Aug 16 2025 |
Life Sciences Industry Basics |
Financial Poise |
| Aug 16 2025 |
Recent Federal Developments for August 2025 |
Bergeson & Campbell, P.C. |
| Aug 15 2025 |
Telehealth and “In-Person Visits”: Tracking Federal and State Updates to Pandemic Era Telehealth Exceptions |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 14 2025 |
S1 E6: Dr. Connie Lehman on AI and the Future of Breast Cancer Prevention [Podcast] |
Polsinelli PC |
| Aug 14 2025 |
Proposed TRUTH in Labeling Act Would Mandate FOP Labeling |
Keller and Heckman LLP |
| Aug 14 2025 |
Judge Upholds New York City Kava Ban |
Keller and Heckman LLP |
| Aug 14 2025 |
FDA in Flux — August 2025 Newsletter |
Mintz |
| Aug 13 2025 |
HRSA Issues 340B Rebate Model Pilot Program Guidance, Requests Comments |
McDermott Will & Schulte LLP |
| Aug 13 2025 |
This Week in 340B: August 5 – 11, 2025 |
McDermott Will & Schulte LLP |
| Aug 13 2025 |
Three Key Reasons Why Securities Class Actions Are Failing on Material Misrepresentation Grounds in the District of Massachusetts |
Pierce Atwood LLP |
| Aug 13 2025 |
Domestic Production of Pharmaceuticals: Are the Administration’s Efforts Enough? |
Blank Rome LLP |
| Aug 13 2025 |
US State Law Roundup |
Squire Patton Boggs (US) LLP |
| Aug 12 2025 |
EC Begins Public Consultation on Biotech Act |
Bergeson & Campbell, P.C. |
| Aug 12 2025 |
Health Care Marketing Enforcement: FTC Targets Telehealth Company for Deceptive Weight Loss Marketing Claims |
Foley & Lardner LLP |
| Aug 12 2025 |
FDA Calls for Stronger Industry Collaboration on Infant and Child Food Recalls |
Foley & Lardner LLP |
| Aug 11 2025 |
Federal and State Agencies Ramp Up Scrutiny of the GLP-1 Drug Market |
Blank Rome LLP |
| Aug 11 2025 |
FDA PreCheck: Fast-Lane Approval to Boost U.S. Drug Manufacturing and Supply Chain Security |
Katten |
| Aug 8 2025 |
Trump Sends Letters to Manufacturers Regarding Most-Favored-Nation Executive Order Requirements |
Mintz |
| Aug 7 2025 |
HRSA Launches and Seeks Comments on 340B Rebate Model Pilot Program |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 7 2025 |
FDA Proposes to Extend Compliance Date for Food Traceability Rule |
Keller and Heckman LLP |
| Aug 7 2025 |
FinCEN Warns Financial Institutions of Illicit Activity at Crypto Kiosks |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 7 2025 |
What to Watch: WHOOP Warning Letter |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 7 2025 |
New Jersey Lawmakers Mull Stronger Labor Protections for Cannabis Industry Workers |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Aug 7 2025 |
The 340B Rebate Pilot: Voluntary for Manufacturers, Costly for 340B Covered Entities |
Polsinelli PC |
| Aug 7 2025 |
HRSA Seeks Applicants to Test 340B Rebate Model Pilot Program |
Epstein Becker & Green, P.C. |
| Aug 7 2025 |
APHIS Seeks Comment on Petition to Deregulate Corn Developed Using Genetic Engineering |
Bergeson & Campbell, P.C. |
| Aug 7 2025 |
Public Comment Period Opens for USDA’s Structural Overhaul |
Keller and Heckman LLP |
| Aug 7 2025 |
FDA Publishes 2025 Guidance Agenda |
Keller and Heckman LLP |
| Aug 7 2025 |
FDA Publishes Proposed Rule Lowering Minimum Brix Content of Pasteurized Orange Juice |
Keller and Heckman LLP |
| Aug 7 2025 |
FDA’s Position on Medical Devices and PFAS |
Greenberg Traurig, LLP |
| Aug 7 2025 |
Is Psychedelic Therapy Legislation on the Horizon in Mississippi? |
Bradley Arant Boult Cummings LLP |
